These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 23074998)

  • 1. Thrombospondins, potential drug targets for cardiovascular diseases.
    Mustonen E; Ruskoaho H; Rysä J
    Basic Clin Pharmacol Toxicol; 2013 Jan; 112(1):4-12. PubMed ID: 23074998
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thrombospondins: A Role in Cardiovascular Disease.
    Chistiakov DA; Melnichenko AA; Myasoedova VA; Grechko AV; Orekhov AN
    Int J Mol Sci; 2017 Jul; 18(7):. PubMed ID: 28714932
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thrombospondin-4 expression is rapidly upregulated by cardiac overload.
    Mustonen E; Aro J; Puhakka J; Ilves M; Soini Y; Leskinen H; Ruskoaho H; Rysä J
    Biochem Biophys Res Commun; 2008 Aug; 373(2):186-91. PubMed ID: 18541142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functions of the conserved thrombospondin carboxy-terminal cassette in cell-extracellular matrix interactions and signaling.
    Adams JC
    Int J Biochem Cell Biol; 2004 Jun; 36(6):1102-14. PubMed ID: 15094125
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of the thrombospondins in healing myocardial infarcts.
    Chatila K; Ren G; Xia Y; Huebener P; Bujak M; Frangogiannis NG
    Cardiovasc Hematol Agents Med Chem; 2007 Jan; 5(1):21-7. PubMed ID: 17266545
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thrombospondin in renal disease.
    Hugo C; Daniel C
    Nephron Exp Nephrol; 2009; 111(3):e61-6. PubMed ID: 19182492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thrombospondin-2 therapy ameliorates experimental glomerulonephritis via inhibition of cell proliferation, inflammation, and TGF-beta activation.
    Daniel C; Wagner A; Hohenstein B; Hugo C
    Am J Physiol Renal Physiol; 2009 Nov; 297(5):F1299-309. PubMed ID: 19726547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thrombospondin-4, tumour necrosis factor-like weak inducer of apoptosis (TWEAK) and its receptor Fn14: novel extracellular matrix modulating factors in cardiac remodelling.
    Mustonen E; Ruskoaho H; Rysä J
    Ann Med; 2012 Dec; 44(8):793-804. PubMed ID: 22380695
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The thrombospondins.
    Adams JC; Lawler J
    Int J Biochem Cell Biol; 2004 Jun; 36(6):961-8. PubMed ID: 15094109
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An association study of thrombospondin 1 and 2 SNPs with coronary artery disease and myocardial infarction among South Indians.
    Ashokkumar M; Anbarasan C; Saibabu R; Kuram S; Raman SC; Cherian KM
    Thromb Res; 2011 Oct; 128(4):e49-53. PubMed ID: 21762961
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Absence of thrombospondin-2 causes age-related dilated cardiomyopathy.
    Swinnen M; Vanhoutte D; Van Almen GC; Hamdani N; Schellings MW; D'hooge J; Van der Velden J; Weaver MS; Sage EH; Bornstein P; Verheyen FK; VandenDriessche T; Chuah MK; Westermann D; Paulus WJ; Van de Werf F; Schroen B; Carmeliet P; Pinto YM; Heymans S
    Circulation; 2009 Oct; 120(16):1585-97. PubMed ID: 19805649
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thrombospondins: old players, new games.
    Stenina-Adognravi O
    Curr Opin Lipidol; 2013 Oct; 24(5):401-9. PubMed ID: 23892609
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thrombospondin-4 in tissue remodeling.
    Stenina-Adognravi O; Plow EF
    Matrix Biol; 2019 Jan; 75-76():300-313. PubMed ID: 29138119
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polymorphisms in thrombospondin genes and myocardial infarction: a case-control study and a meta-analysis of available evidence.
    Koch W; Hoppmann P; de Waha A; Schömig A; Kastrati A
    Hum Mol Genet; 2008 Apr; 17(8):1120-6. PubMed ID: 18178577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Absence of thrombospondin-2 increases cardiomyocyte damage and matrix disruption in doxorubicin-induced cardiomyopathy.
    van Almen GC; Swinnen M; Carai P; Verhesen W; Cleutjens JP; D'hooge J; Verheyen FK; Pinto YM; Schroen B; Carmeliet P; Heymans S
    J Mol Cell Cardiol; 2011 Sep; 51(3):318-28. PubMed ID: 21624372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thrombospondins, their polymorphisms, and cardiovascular disease.
    Stenina OI; Topol EJ; Plow EF
    Arterioscler Thromb Vasc Biol; 2007 Sep; 27(9):1886-94. PubMed ID: 17569883
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathophysiological roles of thrombospondin-4 in disease development.
    Genaro K; Luo ZD
    Semin Cell Dev Biol; 2024 Mar; 155(Pt B):66-73. PubMed ID: 37391348
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased accumulation of extracellular thrombospondin-2 due to low degradation activity stimulates type I collagen expression in scleroderma fibroblasts.
    Kajihara I; Jinnin M; Yamane K; Makino T; Honda N; Igata T; Masuguchi S; Fukushima S; Okamoto Y; Hasegawa M; Fujimoto M; Ihn H
    Am J Pathol; 2012 Feb; 180(2):703-14. PubMed ID: 22142808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The 140-kilodalton antiangiogenic fragment of thrombospondin-1 binds to basic fibroblast growth factor.
    Taraboletti G; Belotti D; Borsotti P; Vergani V; Rusnati M; Presta M; Giavazzi R
    Cell Growth Differ; 1997 Apr; 8(4):471-9. PubMed ID: 9101093
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The antiangiogenic effect of thrombospondin-2 is mediated by CD36 and modulated by histidine-rich glycoprotein.
    Simantov R; Febbraio M; Silverstein RL
    Matrix Biol; 2005 Feb; 24(1):27-34. PubMed ID: 15748999
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.